Sort
21,453 grants matching “tuberculosis”
India International Center for Excellence in Research
$832,521Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Lesion-centric optimization of multidrug therapies for tuberculosis
$832,259Bree Beardsley Aldridge · Tufts University Boston · R01 · FY2021 · AI
Emergence of bedaquiline, pretomanid and linezolid resistance after implementation of new drug-resistant tuberculosis regimens in South Africa
$832,182Barun Mathema · Columbia University Health Sciences · R01 · FY2023 · AI
PROTECTIVE CD8 T CELL RESPONSES to TUBERCULOSIS
$832,076Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AI
Targets in Mycobacterium Tuberculosis: Stress Resistance & Repair
$831,940Carl F Nathan · Weill Medical Coll Of Cornell Univ · R01 · FY2007 · AI
Innovative Approaches to Tuberculosis Control
$831,789Richard E Chaisson · Johns Hopkins University · U19 · FY2006 · AI
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
$830,828John R. Chan · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
Validation of Biomarkers of Pediatric TB and further development for use in diagnosis of childhood TB
$830,713Michael Levin · Imperial College Of Science, Technology And Medicine · R01 · FY2021 · AI
Clinical Trial Site Monitoring for PHOENIx MDR-TB
$830,654Kimberly Smith · Ppd Development Lp · N01 · FY2019 · AI
Pharmacokinetics of Long-Acting Preparations of Antitubercular Drugs in Rodents
$830,604Maria Arolfo · Sri International · N01 · FY2025 · AI
Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection
$830,230Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Biodiversity of Vietnam and Laos
$830,025Djaja D Soejarto · University Of Illinois At Chicago · U01 · FY2006 · TW
Spectinomycin analogs for NTM infections
$829,725Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2022 · AI
GH12-008: The CryptoART Study: Decreasing mortality associated with initiation of antiretro
$829,328Chiratidzo Ellen Ndhlovu · College Of Health Scis Univ Of Zimbabwe · U01 · FY2015 · GH
Development of an engineered CCL20 protein as a lead therapeutic molecule for psoriasis
$829,097Brian F Volkman · Xlock Biosciences, Llc · R44 · FY2021 · AR
Simulating Protein Structures, Complexes, And Dynamics
$829,041Peter J Steinbach · Center For Information Technology · ZIA · FY2009 · CT
The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP)
$828,733Charles W. Flexner · Johns Hopkins University · R24 · FY2023 · AI
Immune Correlates of Protection from TB
$828,491Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2017 · AI
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TB
$828,484Neel Rajnikant Gandhi · Albert Einstein College Of Medicine · R01 · FY2010 · AI
The effect of HIV exposure and infection on immunity to TB in children
$828,368Grace C John-Stewart · University Of Washington · R01 · FY2019 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$828,010Garald Austin Goza · Michigan State Dept Of Public Health · U52 · FY2008 · PS
TUBERCULOSIS ELIMINATION AND LABORATORY
$828,010Melinda Wilkins · Michigan State Dept Of Public Health · U52 · FY2009 · PS
Differentially Culturable Tubercle Bacteria: The missing link in TB Transmission?
$827,855Bavesh Davandra Kana · Wits Health Consortium (Pty), Ltd · R01 · FY2019 · AI
AIDS International Training and Research Program (AITRP)
$827,717Christopher C. Whalen · Case Western Reserve University · D43 · FY2007 · TW
Lesion-centric optimization of multidrug therapies for tuberculosis
$827,669Bree Beardsley Aldridge · Tufts University Boston · R01 · FY2022 · AI